Drug Search Results
More Filters [+]

CardiolRx

Alternative Names: CardiolRx
Latest Update: 2024-10-22
Latest Update Note: News Article

Product Description

CardiolRx is pharmaceutically produced Cannabidiol and is free of tetrahydrocannabinol (THC<5 ppm). (Sourced from: https://clinicaltrials.gov/ct2/show/NCT05180240)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation:
Orphan Drug -
Orphan Drug - Pericarditis *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Cardiol Therapeutics
Company Location: OAKVILLE A6 L6H 0G5
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CardiolRx

Countries in Clinic: Brazil, Canada, France, Israel, United States

Active Clinical Trial Count: 3

Highest Development Phases

Phase 2: Myocarditis|Pericarditis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Cardiol 100-002

P2

Unknown Status

Myocarditis

2025-01-31

ARCHER

P2

Recruiting

Myocarditis

2024-11-01

24%

MAvERIC-Pilot

P2

Completed

Pericarditis

2024-06-15

Recent News Events